Institutional
July 27, 2017
São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending
Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
Click on Download to access the full text of the decision.
Back
Share:
Last related news
December 17, 2021
Kasznar Leonardos announces the promotion of two new partners
We are very proud to announce the promotion of two new partners: Felipe Monteiro, as head of the Sztartup Desk and Matheus … Kasznar Leonardos announces the promotion of two new partners
November 8, 2021
Meet our new visual identity!
For over one hundred years, we have believed in all types of innovation, from market trends and new client products and services … Meet our new visual identity!
June 29, 2021
Kasznar Leonardos donates basic foodstuffs to families in Rio de Janeiro and Sao Paulo
As part of its Social Responsibility Program, Kasznar Leonardos donated over 700 packages of basic foodstuffs through the “Gramachinhos” Project in Rio … Kasznar Leonardos donates basic foodstuffs to families in Rio de Janeiro and Sao Paulo